Chemerin binds to the receptors CMKLR1, GPR1 or CCRL2 to recruit immune cells, which then regulate the immune inflammatory response of the body and assume antitumor and protumor roles in tumor progression through interactions with different pathways. The gene discussed is CCRL2; the disease is neoplasm.